Ultragenyx Pharmaceutical Inc. (RARE)

USD 42.94

(-4.47%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 1.49 Billion 1.54 Billion 1.52 Billion 1.75 Billion 1.13 Billion 719.55 Million
Total Current Assets 732.18 Million 883.89 Million 856.6 Million 1.29 Billion 851.01 Million 522.36 Million
Cash And Short Term Investments 777.11 Million 896.73 Million 999.12 Million 1.21 Billion 760.4 Million 459.7 Million
Cash and Cash Equivalents 213.58 Million 132.94 Million 307.58 Million 713.52 Million 433.58 Million 113.43 Million
Short Term Investments 363.62 Million 614.81 Million 432.61 Million 488 Million 321.64 Million 346.27 Million
Net Receivables 73.39 Million 40.44 Million 28.43 Million 23.09 Million 32.84 Million 12.74 Million
Inventory 33.96 Million 26.76 Million 16.23 Million 13.04 Million 11.54 Million 7.06 Million
Other Current Assets -777.11 Million 68.92 Million -187.18 Million 47.12 Million 46.22 Million 42.85 Million
Total Non-Current Assets 758.82 Million 661.54 Million 665.79 Million 464.25 Million 284.47 Million 197.18 Million
Net PPE 290.56 Million 285.68 Million 176.18 Million 114.03 Million 74.67 Million 20.04 Million
Good Will And Intangible Assets 210.67 Million 204.51 Million 175.19 Million 175.51 Million 173.4 Million 173.62 Million
Good Will 44.4 Million 44.4 Million 44.4 Million 44.4 Million 44.4 Million 44.4 Million
Intangible Assets 166.27 Million 160.1 Million 130.78 Million 131.11 Million 129 Million 129.22 Million
Long-Term Investments 199.9 Million 154.5 Million 293.85 Million 165.88 Million 32.92 Million 1.82 Million
Tax Assets 5.95 Million 6.14 Million 8.94 Million 33.34 Million 7.66 Million -1.82 Million
Other Non Current Assets 51.72 Million 10.7 Million 11.61 Million -24.53 Million -4.19 Million 3.51 Million
Other Assets - - - - - -
Total Liabilities 1.21 Billion 1.19 Billion 599.83 Million 605.18 Million 481.73 Million 110.65 Million
Total Current Liabilities 280.43 Million 261.21 Million 181.36 Million 189.6 Million 103.3 Million 74.72 Million
Account Payables 42.11 Million 43.27 Million 17.13 Million 12.92 Million 12.87 Million 12.27 Million
Tax Payables - - - - - -
Short Term Debt 12.59 Million 11.77 Million 11.06 Million 8.97 Million 7.23 Million -
Deferred Revenue 196.48 Million 1.47 Million 7.6 Million 59.21 Million - -
Other Current Liabilities 29.24 Million 204.67 Million 145.55 Million 108.49 Million 83.19 Million 62.45 Million
Total Non Current Liabilities 935.16 Million 931.74 Million 418.46 Million 415.57 Million 378.43 Million 35.92 Million
Long-Term Debt 30.57 Million 19.81 Million 30.9 Million 39.25 Million 29.75 Million -
Deferred Revenue Non Current 862.32 Million - 1.46 Million 7.34 Million - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 12.2 Million 880.25 Million 352.79 Million 335.66 Million 315.36 Million 4.75 Million
Other Liabilities - - - - - -
Total Equity 275.41 Million 352.49 Million 922.56 Million 1.15 Billion 653.76 Million 608.9 Million
Stock Holders Equity 275.41 Million 352.49 Million 922.56 Million 1.15 Billion 653.76 Million 608.9 Million
Common Stock 82 Thousand 70 Thousand 69 Thousand 67 Thousand 58 Thousand 51 Thousand
Retained Earnings -3.38 Billion -2.78 Billion -2.07 Billion -1.61 Billion -1.43 Billion -1.03 Billion
Accumulated other comprehensive income 647 Thousand -6.57 Million -1.4 Million 689 Thousand -147 Thousand -633 Thousand
Common Stock Equity 275.41 Million 352.49 Million 922.56 Million 1.15 Billion 653.76 Million 608.9 Million
Capital Lease Obligation 43.16 Million 31.59 Million 41.97 Million 48.22 Million 36.99 Million -
Total Investments 563.52 Million 620.34 Million 726.47 Million 653.88 Million 354.57 Million 346.27 Million
Total Debt 43.16 Million 31.59 Million 41.97 Million 48.22 Million 36.99 Million -
Net Debt -170.41 Million -101.35 Million -265.61 Million -665.29 Million -396.59 Million -113.43 Million

Balance Sheet Charts